EE03597B1 - Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini - Google Patents

Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini

Info

Publication number
EE03597B1
EE03597B1 EE9700269A EE9700269A EE03597B1 EE 03597 B1 EE03597 B1 EE 03597B1 EE 9700269 A EE9700269 A EE 9700269A EE 9700269 A EE9700269 A EE 9700269A EE 03597 B1 EE03597 B1 EE 03597B1
Authority
EE
Estonia
Prior art keywords
arginine
pharmaceutical composition
lactobacillus plantarum
composition
curative
Prior art date
Application number
EE9700269A
Other languages
English (en)
Estonian (et)
Other versions
EE9700269A (et
Inventor
Adawi Diya
Jeppsson Bengt
Molin G�ran
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of EE9700269A publication Critical patent/EE9700269A/xx
Publication of EE03597B1 publication Critical patent/EE03597B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EE9700269A 1995-05-09 1996-05-08 Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini EE03597B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition
PCT/SE1996/000603 WO1996035440A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine

Publications (2)

Publication Number Publication Date
EE9700269A EE9700269A (et) 1998-04-15
EE03597B1 true EE03597B1 (et) 2002-02-15

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700269A EE03597B1 (et) 1995-05-09 1996-05-08 Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini

Country Status (16)

Country Link
EP (1) EP0825869B1 (xx)
JP (1) JP4058560B2 (xx)
KR (1) KR19990008403A (xx)
CN (1) CN1152678C (xx)
AT (1) ATE221783T1 (xx)
AU (1) AU704886B2 (xx)
BR (1) BR9608284A (xx)
CA (1) CA2220498A1 (xx)
DE (2) DE825869T1 (xx)
EE (1) EE03597B1 (xx)
ES (1) ES2112818T3 (xx)
GR (1) GR980300028T1 (xx)
NO (1) NO317668B1 (xx)
PL (1) PL184603B1 (xx)
SE (1) SE9501719D0 (xx)
WO (1) WO1996035440A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
ES2276793T3 (es) 2000-03-24 2007-07-01 Societe Des Produits Nestle S.A. Empleo de la bacteria del acido lactico para la prevencion de la peritonitis.
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
JP4947636B2 (ja) 2004-03-31 2012-06-06 カルピス株式会社 肝障害予防又は抑制剤
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
DK3067057T3 (da) * 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
JP5823695B2 (ja) * 2008-12-03 2015-11-25 国立大学法人広島大学 肝機能障害予防剤
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌cmu995菌株之新用途
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
EP4444332A1 (en) * 2021-12-09 2024-10-16 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
PL323320A1 (en) 1998-03-16
NO975136L (no) 1997-11-07
GR980300028T1 (en) 1998-04-30
WO1996035440A1 (en) 1996-11-14
NO975136D0 (no) 1997-11-07
BR9608284A (pt) 1999-06-08
SE9501719D0 (sv) 1995-05-09
KR19990008403A (ko) 1999-01-25
CN1190346A (zh) 1998-08-12
ES2112818T1 (es) 1998-04-16
NO317668B1 (no) 2004-11-29
EE9700269A (et) 1998-04-15
EP0825869B1 (en) 2002-08-07
JPH11504936A (ja) 1999-05-11
CA2220498A1 (en) 1996-11-14
ES2112818T3 (es) 2003-02-16
PL184603B1 (pl) 2002-11-29
CN1152678C (zh) 2004-06-09
DE69622855D1 (de) 2002-09-12
JP4058560B2 (ja) 2008-03-12
ATE221783T1 (de) 2002-08-15
AU704886B2 (en) 1999-05-06
EP0825869A1 (en) 1998-03-04
DE825869T1 (de) 1998-07-16
DE69622855T2 (de) 2003-04-10
AU5784696A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
EE03597B1 (et) Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
MY120501A (en) Micro-encapsulated lactobacilli for medical applications
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0203185A2 (hu) Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus
BR0112685A (pt) Composição nutricional
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
HK1051490A1 (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs.
JPS6483025A (en) Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
Samuel Paediatrics Forum. Acute diarrhoea
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
UA31364A (uk) Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит
UA49889C2 (uk) Антибактеріальний препарат "бороцин"
UA30011A (uk) Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20070508